0.39
-0.002(-0.51%)
Currency In USD
| Previous Close | 0.39 |
| Open | 0.38 |
| Day High | 0.39 |
| Day Low | 0.37 |
| 52-Week High | 0.98 |
| 52-Week Low | 0.26 |
| Volume | 121,291 |
| Average Volume | 1.94M |
| Market Cap | 88.82M |
| PE | -1.69 |
| EPS | -0.23 |
| Moving Average 50 Days | 0.38 |
| Moving Average 200 Days | 0.5 |
| Change | -0 |
If you invested $1000 in Vaxart, Inc. (VXRT) 10 years ago, it would be worth $17.64 as of September 18, 2025 at a share price of $0.388. Whereas If you bought $1000 worth of Vaxart, Inc. (VXRT) shares 5 years ago, it would be worth $47.2 as of September 18, 2025 at a share price of $0.388.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vaxart Appoints W. Mark Watson as Lead Independent Director
GlobeNewswire Inc.
5 hours ago
In process of adopting a Director stock ownership policy to reinforce commitment of aligning the Board’s interests with stockholders Vaxart encourages all stockholders of record on July 29, 2025, who have not yet voted FOR the reverse stock split, to
Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate
GlobeNewswire Inc.
Sep 10, 2025 8:54 PM GMT
- Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against infection in the company’s previous Phase 2b challenge study - SOUTH SAN FRANCISCO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE
Vaxart Announces Adjournment of Special Meeting of Stockholders
GlobeNewswire Inc.
Sep 08, 2025 12:00 PM GMT
Meeting adjourned to September 19, 2025 at 8:30 a.m. Pacific Time Adjournment provides stockholders with more time given changes in Board composition, additional governance change considerations and future potential disclosures Vaxart encourages all